Dmitry Balyasny Balyasny Asset Management
Dmitry Balyasny is the founder of Balyasny Asset Management, a major multi-strategy and multi-manager hedge fund platform. The firm allocates capital across fundamental equities, macro, quant, and other teams under a central risk framework. Balyasny’s platform is often cited alongside other leading pod-shop multi-strategy firms.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$366M |
| 2 |
Wells Fargo
WFC
|
+$158M |
| 3 |
STI
SunTrust Banks, Inc.
STI
|
+$157M |
| 4 |
Dollar Tree
DLTR
|
+$151M |
| 5 |
Evergy
EVRG
|
+$149M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Walt Disney
DIS
|
+$229M |
| 2 |
Alcoa
AA
|
+$206M |
| 3 |
Visa
V
|
+$130M |
| 4 |
Darden Restaurants
DRI
|
+$127M |
| 5 |
Northern Trust
NTRS
|
+$127M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 17.41% |
| 2 | Consumer Discretionary | 13.39% |
| 3 | Technology | 10.01% |
| 4 | Real Estate | 8.2% |
| 5 | Industrials | 7.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1426
CoStar Group
CSGP
$13.3B
| $385K | ﹤0.01% |
9,330
-93,680
| -91% | -$3.61M |
|
1427
Voyager Therapeutics
VYGR
$214M
| $382K | ﹤0.01% |
19,569
+7,894
| +68% | +$156K |
|
|
ZEN
1428
DELISTED
ZENDESK INC
ZEN
| $382K | ﹤0.01% |
7,019
-2,967
| -30% | -$158K |
|
1429
CytomX Therapeutics
CTMX
$734M
| $380K | ﹤0.01% |
16,632
+1,157
| +7% | +$29.6K |
|
|
ISCA
1430
DELISTED
International Speedway Corp
ISCA
| $380K | ﹤0.01% |
8,499
-4,100
| -33% | -$173K |
|
1431
Great Southern Bancorp
GSBC
$857M
| $378K | ﹤0.01% |
6,602
-400
| -6% | -$22.2K |
|
|
SPTN
1432
DELISTED
SpartanNash
SPTN
| $378K | ﹤0.01% |
14,810
-500
| -3% | -$10.3K |
|
|
LTRPA
1433
DELISTED
Liberty TripAdvisor Holdings, Inc. Series A
LTRPA
| $378K | ﹤0.01% |
23,482
+11,664
| +99% | +$151K |
|
1434
Cactus
WHD
$5.38B
| $377K | ﹤0.01% |
11,150
-84,372
| -88% | -$2.61M |
|
|
ACRE
1435
Ares Commercial Real Estate
ACRE
$264M
| $376K | ﹤0.01% |
27,231
-15,116
| -36% | -$200K |
|
1436
Fulton Financial
FULT
$4.52B
| $376K | ﹤0.01% |
22,762
-761,683
| -97% | -$13.2M |
|
|
SEMG
1437
DELISTED
SEMGROUP CORPORATION
SEMG
| $376K | ﹤0.01% |
+14,816
| New | +$363K |
|
1438
Westwood Holdings Group
WHG
$187M
| $375K | ﹤0.01% |
6,300
-1,000
| -14% | -$58.3K |
|
1439
MaxLinear
MXL
$6.01B
| $371K | ﹤0.01% |
+23,767
| New | +$480K |
|
|
PETQ
1440
DELISTED
PetIQ, Inc. Class A Common Stock
PETQ
| $370K | ﹤0.01% |
+13,782
| New | +$299K |
|
1441
Materion
MTRN
$4.84B
| $369K | ﹤0.01% |
+6,817
| New | +$370K |
|
1442
Winnebago Industries
WGO
$902M
| $367K | ﹤0.01% |
9,034
-12,155
| -57% | -$464K |
|
1443
CNX Resources
CNX
$5.33B
| $365K | ﹤0.01% |
20,529
-37,524
| -65% | -$602K |
|
1444
Enviri
NVRI
$610M
| $364K | ﹤0.01% |
16,481
-20,879
| -56% | -$482K |
|
1445
Waterstone Financial
WSBF
$378M
| $364K | ﹤0.01% |
21,366
-4,600
| -18% | -$80.4K |
|
|
CTRL
1446
DELISTED
Control4 Corporation
CTRL
| $363K | ﹤0.01% |
14,933
-31,033
| -68% | -$725K |
|
|
QTNA
1447
DELISTED
Quantenna Communications, Inc. Common Stock
QTNA
| $363K | ﹤0.01% |
+23,373
| New | +$349K |
|
|
AVNS
1448
DELISTED
Avanos Medical
AVNS
| $362K | ﹤0.01% |
+6,317
| New | +$334K |
|
1449
Yext
YEXT
$660M
| $362K | ﹤0.01% |
+18,730
| New | +$287K |
|
1450
Abeona Therapeutics
ABEO
$355M
| $360K | ﹤0.01% |
+900
| New | +$393K |
|
Similar funds
Dmitry Balyasny's Q2 2018 Portfolio in Review
As of Q2 2018, Dmitry Balyasny held 2,414 positions worth $22B, down 8% from $23.9B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Dmitry Balyasny withdrew a net $2.72B in Q2 2018, closing 678 positions and reducing 664 holdings. Its most notable exit was Burlington, an estimated $114M position sold in full.
By sector, the portfolio is most concentrated in Financials at 17% of assets, down from 19% a quarter earlier, followed by Consumer Discretionary and Technology.
Against the trend, Dmitry Balyasny opened a new position in Evergy worth $156M.
- Dmitry Balyasny's largest Q2 2018 buy was Evergy: 2,779,050 shares worth $156M.
- Dmitry Balyasny added most to State Street SPDR S&P 500 ETF Trust in Q2 2018, an estimated $366M increase.
- Dmitry Balyasny's biggest Q2 2018 reduction was Walt Disney, cutting an estimated $229M.
- Dmitry Balyasny fully exited Burlington in Q2 2018, selling an estimated $114M.
- Dmitry Balyasny's ten largest holdings make up 11% of its $22B portfolio in Q2 2018.
- Dmitry Balyasny opened 528 new positions and closed 678 in Q2 2018.
- Dmitry Balyasny's portfolio value fell 8% quarter-over-quarter to $22B.
Based on Balyasny Asset Management's 13F filing for Q2 2018, filed 14 Aug 2018.